Oligodendrocytes: biology and pathology
Open accessThe DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
Oligodendrocytes are the myelinating cells of the central nervous system (CNS). They are the end product of a cell lineage which has to undergo a complex and precisely timed program of proliferation, migration, differentiation, and myelination to finally produce the insulating sheath of axons. Due to this complex differentiation program, and due to their unique metabolism/physiology, oligodendrocytes count among the most vulnerable cells of the CNS. In this review, we first describe the different steps eventually culminating in the formation of mature oligodendrocytes and myelin sheaths, as they were revealed by studies in rodents. We will then show differences and similarities of human oligodendrocyte development. Finally, we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases, and we will reveal the different principles leading to the restoration of myelin sheaths or to a failure to do so.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Myelin and oligodendrocyte pathology in autoimmune encephalomyelitis, multiple sclerosis, and stroke. a–d Chronic autoimmune encephalomyelitis, induced in DA rat by active sensitization with MOG fusion protein; a massive demyelination is seen in the cerebellar white matter, ×6; b–d oligodendrocytes in different lesion stages of EAE; in the peri-plaque white matter myelin (red) is present and multiple oligodendrocytes with PLP mRNA (black) are seen (b); in the active lesions myelin falls apart, myelin fragments are taken up by macrophages (red granules) and oligodendrocytes are lost (c); in more advanced lesions no macrophages with early myelin degradation products are present; numerous oligodendrocytes re-appear in the lesions, apparently recruited from progenitor cells (black cells), followed by rapid and extensive remyelination; immunocytochemistry for PLP and in situ hybridization for PLP mRNA, ×1000; e–h chronic multiple sclerosis case with extensive remyelination within the CNS; This hemispheric brain section contains 3 active lesions, 4 demyelinated plaques, and 8 remyelinated shadow plaques, ×1.2; f–h double staining for PLP protein (red) and PLP mRNA (black) in one of the active lesions shows a similar pattern as described before in EAE; many oligodendrocytes in the peri-plaque white matter (f); oligodendrocyte loss in the zone of active demyelination (g) and reappearance of oligodendrocytes in the inactive zone, closely adjacent to the zone of activity (h), ×500; i–o myelin changes in the initial stage of a lesion in white matter stroke; LFB shows pale myelin staining (i); the axons, stained with Bielschowsky silver impregnation are largely preserved (k); MAG (l) and CNPase (m) are completely lost from the lesions, while the myelin proteins within the compact sheath (PLP; n) or on the oligodendrocyte surface (MOG; o) are preserved, ×20; p–s acute multiple sclerosis with lesions following a pattern of hypoxia-like tissue injury (Pattern III, [109]). p The section contains areas of initial demyelination (i), early active demyelination (a) and late active or inactive portions (d); q serial section of p, stained by immunocytochemistry for PLP; Only the late active and inactive lesions show loss of PLP; in the active portions (a) a minor loss of PLP reactivity is seen, while in the initial lesions PLP reactivity is the same as in the normal appearing white matter, ×3; r and s edge of an active lesion showing partial preservation of immunoreactivity for MOG (r), but extensive and complete loss of MAG(s), ×20](https://figures.cochat.ai/paper-figures/777f35f33b804c4caf0983c7191aaa36/oligodendrocytes-biology-and-pathology-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, module 14 was enriched in genes involved in myelination49 and blood-brain barrier,50 consistent with the high enrichment of oligodendrocyte populations in the fiber tracts, and indicated blood-brain barrier changes in the thalamus.”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes have a high metabolic rate and must produce large amounts of membranes and protein, particularly during myelination (Bradl & Lassmann, 2010).”
From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Bradl & Lassmann, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
McLaurin, J., & Yong, V. W. (1995) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30060-4 · Cited by 64
Redwine, J. M., Blinder, K. L., & Armstrong, R. C. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971015)50:2<229::aid-jnr11>3.0.co;2-3 · Cited by 64 · cited 2×
“OPC migration is guided by regulatory signals To date, three different classes of secreted molecules seem to be involved in the migration of OPCs: growth factors like PDGF, FGF [155, 174] or hepatocyte growth factor [211, 138]; chemotropic molecules like netrins and secre- ted semaphorins [74, 193]; and the chemokine…”
BackgroundOligodendroglial impact on axonal function and survival – a hypothesis
Kassmann, C. M., & Nave, K.-A. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328300c71f · Cited by 63
Control of axonophilic migration of oligodendrocyte precursor cells by Eph–ephrin interaction
PRESTOZ, L., CHATZOPOULOU, E., LEMKINE, G., SPASSKY, N., LEBRAS, B., KAGAWA, T., IKENAKA, K., ZALC, B., & THOMAS, J.-L. (2004) · Neuron Glia Biology · doi:10.1017/s1740925x04000109 · Cited by 54 · cited 2×
“OPC migration is not only controlled by secreted molecules, but is also regulated by contact-mediated mechanisms involving many different extracellular matrix proteins and cell surface molecules [52, 88, 199], N-cadherins [125, 133, 145, 167, 190], and possibly even additional, yet unidentified molecules.”
BackgroundRegulation of sphingomyelinases in cells of the oligodendrocyte lineage
Testai, F. D., Landek‐Salgado, M. A., & Dawson, G. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10816 · Cited by 50
Induction of intracellular ceramide by interleukin-1β in oligodendrocytes
Brogi, A., Strazza, M., Melli, M., & Costantino-Ceccarini, E. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970915)66:4<532::aid-jcb12>3.0.co;2-d · Cited by 49
Bradl, M., Bauer, J., Inomata, T., Zielasek, J., Nave, K., Toyka, K. V., Lassmann, H., & Wekerle, H. (1999) · Acta Neuropathologica · doi:10.1007/s004010051035 · Cited by 48
Self-citationLisak, R. P., Benjamins, J. A., Bealmear, B., Nedelkoska, L., Studzinski, D., Retland, E., Yao, B., & Land, S. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-4 · Cited by 41
Release of Adenine Nucleotide from Nerve Axons
Kuperman, A. S., Volpert, W. A., & OKAMOTO, M. (1964) · Nature · doi:10.1038/2041000a0 · Cited by 40
Goldbaum, O., Jensen, P. H., & Richter‐Landsberg, C. (2008) · Glia · doi:10.1002/glia.20720 · Cited by 36
Omlin, F. X. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00283-9 · Cited by 30
Maire, J. C., Medilanski, J., & Straub, R. W. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015489 · Cited by 29
Preusser, M., Lehotzky, A., Budka, H., Ovádi, J., & Kovács, G. G. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0173-6 · Cited by 29
Axonal degeneration stimulates the formation of NG2+ cells and oligodendrocytes in the mouse
Nielsen, H. H., Ladeby, R., Drøjdahl, N., Peterson, A. C., & Finsen, B. (2006) · Glia · doi:10.1002/glia.20357 · Cited by 28
Carboxyl terminus of mitosin is sufficient to confer spindle pole localization
Zhu, X., Ding, L., & Pei, G. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970915)66:4<450::aid-jcb4>3.0.co;2-k · Cited by 27
[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu, T., Fujihara, K., & Itoyama, Y. (2008) · PubMed · Cited by 25
Givre, S. J. (2003) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-200306000-00025 · Cited by 16
Hirner, A. (1969) · Acta Neuropathologica · doi:10.1007/bf00686123 · Cited by 15
Immunocytology of carbonic anhydrase II in the central nervous system of jimpy mutant mice
Borrelli, E., Langley, O. K., Ghandour, M. S., Delaunoy, J., & Gombos, G. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90314-7 · Cited by 11
[Neuropathology of progressive multifocal leukoencephalopathy].
Murayama, S., & Saito, Y. (2007) · PubMed · Cited by 5
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Self-citation(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9861(19981012)400:1
(1996) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1136(199606)17:2
Research works printed but not linked: 4
- Cheepsunthorn P, Palmer C, Connor JR (1998) Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol 400:73–86 · doi:10.1002/(sici)1096-9861(19981012)400:1<73::aid-cne5>3.0.co;2-q
- Connor RR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17:83–93 · doi:10.1002/(sici)1098-1136(199606)17:2<83::aid-glia1>3.0.co;2-7
- Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717 · DOI
- Schlesinger H (1909) Zur Frage der akuten Multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter. Arb Neurol Inst (Wien) 17:410–432
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01310 · Cited by 755
Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639
“Oligodendrocytes are known to express receptors for various cytokines and chemokines [162].”
BackgroundOligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625
“They are generated from oligodendrocyte progenitor cells following tightly orchestrated processes of migration, proliferation and differentiation [1].”
BackgroundInfluentialGuidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Metadata
- Authors
- Bradl, M., & Lassmann, H.
- Affiliations
- Medical University of Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Bradl, Monika
- Venue
- Acta Neuropathologica
- Published
- 2009-10-22
- Volume
- 119
- Issue
- 1
- Pages
- 37-53
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2799635
- OpenAlex
- W2018558728
- Cited by
- 933
- References
- 221
- Citations by year
- 2026: 66 · 2025: 67 · 2024: 85 · 2023: 69 · 2022: 74 · 2021: 84 · 2020: 61 · 2019: 72 · 2018: 50 · 2017: 46 · 2016: 44 · 2015: 39 · 2014: 41 · 2013: 51 · 2012: 28
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Austrian Science Fund (P 19854)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oligodendrocytes, myelination, myelin sheath, oligodendrocyte lineage, oligodendrocyte differentiation, demyelination, demyelinating disease, central nervous system
- MeSH terms
- Animals, Central Nervous System, Central Nervous System Diseases, Humans, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Species Specificity, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.